Brief: Tscan Therapeutics Announces 2023 Clinical Plans
05/01/2023 12:20
Jan 5 (Reuters) - TScan Therapeutics Inc TCRX.O :
* TSCAN THERAPEUTICS ANNOUNCES 2023 CLINICAL PLANS AND
HIGHLIGHTS
RECENT PROGRESS
* TSCAN THERAPEUTICS INC - PHASE 1 UMBRELLA TRIAL OF TSC-100
AND
TSC-101 ACTIVE IN FIVE SITES
* TSCAN THERAPEUTICS INC - CASH RUNWAY FUNDS OPERATIONS INTO
2Q
2024
Source text for Eikon: ID:nGNX2zYHQv
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing